As part of the Inflation Reduction Act, out-of-pocket costs for insulin are capped at $35 per month prescription for enrollees of Medicare Part B and Part D.
Although President Joe Biden wasn’t able to extend that cap to people not on Medicare in the IRA, the political pressure he has brought to this fight has caused major drug manufacturers to cap the cost of prescriptions for insulin to $35 per month for millions of people not on Medicare.